An antidepressant that Andrea Yates had been taking before she drowned her five children in 2001 has recently been found to possibly increase the risk of homicidal thoughts, according to a medical ...

Consumers who wish to report an adverse event should contact their doctor and report it to the FDA's MedWatch Safety Information and Adverse Event Reporting Program by completing a form online or by ...

Venlafaxine (as HCl) 37.5mg, 75mg, 150mg; ext-rel caps. Effexor XR is supplied in 15-, 30-, and 90-count bottles, and a carton of 10 Redipak blister strips of 10 capsules each. Effexor XR is available ...

Venlafaxine should be avoided when using alcohol since it causes drowsiness, dizziness and an increased risk of Central Nervous System depression (1 Trusted Source National Institute on Alcohol and ...

MADISON, N.J. Wyeth has settled a patent-infringement case with Osmotica Pharmaceuticals over its antidepressant drug Effexor XR, according to published reports. Under the terms of the deal Osmotica ...

Venlafaxine (Venset (75 mg)) is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI), prescribed for depression, generalized anxiety disorder, social anxiety disorder, and panic ...

June 29, 2010 — The US Food and Drug Administration (FDA) has approved the first generic version of venlafaxine HCl extended-release capsules (Teva Pharmaceuticals, Inc; brand name Effexor XR; Wyeth ...

Of course, the drugmakers have their own points of view about their Effexor XR patent settlement. "Pfizer categorically denies the claims asserted in the plaintiffs' complaints," spokesman Christopher ...

Madison, NJ, February 11, 2003 -- Wyeth (NYSE:WYE) announced today that the U.S. Food and Drug Administration (FDA) approved EFFEXOR (R) XR (venlafaxine HCl) for the treatment of patients with social ...

PHILADELPHIA Wyeth Pharmaceuticals is about to be hit by a generic launch, according to published reports. Wyeth’s antidepressant drug, Effexor, is on pace to have sales exceed $3.7 billion, but Sun ...

NEW YORK – Eli Lilly & Co. (LLY) Wednesday said U.S. regulators have approved its new antidepressant, Cymbalta, a drug that analysts say will be central to the company's growth. The Food and Drug ...